Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant

被引:2
|
作者
Yelskaya, Zarina [1 ]
Arnold, Angela G. [2 ]
Marcell, Vanessa J. [2 ]
Tang, Laura H. [1 ]
Salo-Mullen, Erin E. [2 ]
Strong, Vivian [3 ]
Stadler, Zsofia K. [2 ]
Zhang, Liying [1 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
关键词
D O I
10.1038/s41431-021-00825-w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hereditary Diffuse Gastric Cancer (HDGC) syndrome is associated with CDH1 germline likely pathogenic/pathogenic variants. Carriers of CDH1 germline likely pathogenic/pathogenic variants are predisposed to diffuse gastric cancer and lobular breast cancer. This study aims to classify the CDH1 c.[715G>A] missense variant identified in a diffuse gastric cancer prone family by performing splicing studies. RT-PCR and subsequent cloning experiments were performed to investigate whether this variant completely disrupts normal splicing. This variant preferentially abolishes normal splicing through activation of a cryptic 3 ' acceptor splice site within exon 6 of CDH1, presumably leading to a premature protein truncation within first extracellular domain repeat of E-cadherin protein. Our results contributed to evidence necessary to resolve pathogenicity classification of this variant, indicating that this variant is to be classified as pathogenic.
引用
收藏
页码:1103 / 1109
页数:7
相关论文
共 50 条
  • [31] Substantial evidence for the clinical significance of missense variant BRCA1 c.5309G>T p.(Gly1770Val)
    Emma Tudini
    Setareh Moghadasi
    Michael T. Parsons
    Lizet van der Kolk
    Ans M. W. van den Ouweland
    Dieter Niederacher
    Lídia Feliubadaló
    Barbara Wappenschmidt
    Amanda B. Spurdle
    Conxi Lazaro
    Breast Cancer Research and Treatment, 2018, 172 : 497 - 503
  • [32] Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome
    Farrell, Michael P.
    Hughes, David J.
    Berry, Ian R.
    Gallagher, David J.
    Glogowski, Emily A.
    Payne, Stewart J.
    Kennedy, Michael J.
    Clarke, Roisin M.
    White, Susan A.
    Muldoon, Cian B.
    Macdonald, Fiona
    Rehal, Pauline
    Crompton, Danielle
    Roring, Solvig
    Duke, Sarah T.
    McDevitt, Trudi
    Barton, David E.
    Hodgson, Shirley V.
    Green, Andrew J.
    Daly, Peter A.
    FAMILIAL CANCER, 2012, 11 (03) : 509 - 518
  • [33] Evidence supporting the pathogenicity of the NADSYN1 c.1717G>A (p.Ala573Thr) variant in individuals referred for clinical testing
    Sybouts, Erin
    Bend, Renee
    Allingham-Hawkins, Diane
    Weber, James
    GENETICS IN MEDICINE, 2022, 24 (03) : S254 - S254
  • [34] Substantial evidence for the clinical significance of missense variant BRCA1 c.5309G>T p.(Gly1770Val)
    Tudini, Emma
    Moghadasi, Setareh
    Parsons, Michael T.
    van der Kolk, Lizet
    van den Ouweland, Ans M. W.
    Niederacher, Dieter
    Feliubadalo, Lidia
    Wappenschmidt, Barbara
    Spurdle, Amanda B.
    Lazaro, Conxi
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (02) : 497 - 503
  • [35] RYR1 variant c.38T>G, p.Leu13Arg causes hypersensitivity of the ryanodine receptor-1 and is pathogenic for malignant hyperthermia
    van den Bersselaar, L. R.
    Greven, T.
    Bulger, T.
    Voermans, N. C.
    van Petegem, F.
    Schiemann, A. H.
    Parker, R.
    Burling, S. M.
    Jungbluth, H.
    Stowell, K. M.
    Kamsteeg, E. J.
    Snoeck, M. M. J.
    BRITISH JOURNAL OF ANAESTHESIA, 2021, 127 (02) : E63 - E65
  • [36] Hemoglobin Daneshgah-Tehran (HBA1:c.218A>G p.His72Arg): a Rare α1-Globin Variant from Iran
    Jalali, Hossein
    Mahdavi, Mohammad Reza
    Karami, Hosein
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2020, 10 (03) : 200 - 202
  • [37] High-efficiency genetic correction of primary hyperoxaluria type 1 causing AGXT variant, c.508G>A (Gly170Arg) with an adenine base editor in patient-derived fibroblasts
    Keskinen, T.
    Jalil, S.
    Hyvonen, M. E.
    Wartiovaara, K.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A250 - A250
  • [38] A second patient with Classical Ehlers-Danlos Syndrome (cEDS) and congenital hip dislocation caused by the pathogenic variant COL1A1 c. 934C>T, p.Arg312Cys
    Duong, J.
    Rideout, A.
    Beis, J.
    Parkash, S.
    Schwarze, U.
    Vandersteen, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 107 - 107
  • [39] The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
    Moghadasi, Setareh
    Meeks, Huong D.
    Vreeswijk, Maaike P. G.
    Janssen, Linda A. M.
    Borg, Ake
    Ehrencrona, Hans
    Paulsson-Karlsson, Ylva
    Wappenschmidt, Barbara
    Engel, Christoph
    Gehrig, Andrea
    Arnold, Norbert
    Hansen, Thomas Van Overeem
    Thomassen, Mads
    Jensen, Uffe Birk
    Kruse, Torben A.
    Ejlertsen, Bent
    Gerdes, Anne-Marie
    Pedersen, Inge Sokilde
    Caputo, Sandrine M.
    Couch, Fergus
    Hallberg, Emily J.
    van den Ouweland, Ans M. W.
    Collee, Margriet J.
    Teugels, Erik
    Adank, Muriel A.
    van der Luijt, Rob B.
    Mensenkamp, Arjen R.
    Oosterwijk, Jan C.
    Blok, Marinus J.
    Janin, Nicolas
    Claes, Kathleen B. M.
    Tucker, Kathy
    Viassolo, Valeria
    Toland, Amanda Ewart
    Eccles, Diana E.
    Devilee, Peter
    Van Asperen, Christie J.
    Spurdle, Amanda B.
    Goldgar, David E.
    Garcia, Encarna Gomez
    JOURNAL OF MEDICAL GENETICS, 2018, 55 (01) : 15 - 20
  • [40] Identification and Functional Analysis of a SLC33A1: c.339T>G (p.Ser113Arg) Variant in the Original SPG42 Family
    Mao, Fei
    Li, Zhaohui
    Zhao, Baoyue
    Lin, Pengfei
    Liu, Pingting
    Zhai, Meng
    Liu, Qiji
    Shao, Changshun
    Sun, Wenjie
    Gong, Yaoqin
    HUMAN MUTATION, 2015, 36 (02) : 240 - 249